Carlyle
Latest statistics and disclosures from Carlyle Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are QDEL, ZI, MKSI, VTRU, GDS, and represent 89.07% of Carlyle Group's stock portfolio.
- Added to shares of these 10 stocks: PCVX (+$72M), VRNA (+$49M), HLVX (+$30M), VERA (+$23M), PHAT (+$21M), JSPR (+$16M), INVH (+$15M), RPHM (+$12M), ACET (+$12M), SPRB (+$6.4M).
- Started 19 new stock positions in CBAY, NCNA, HLVX, JSPR, MTEM, AGLE, PCVX, EFTR, SPRB, XCUR. SLNO, ACET, PHAT, INVH, Sientra, RPHM, VRNA, PRTK, VERA.
- Reduced shares in these 2 stocks: 1life Healthcare (-$228M), SPNT.
- Sold out of its positions in 1life Healthcare, SPNT.
- Carlyle Group was a net buyer of stock by $47M.
- Carlyle Group has $3.4B in assets under management (AUM), dropping by -2.47%.
- Central Index Key (CIK): 0001527166
Tip: Access up to 7 years of quarterly data
Positions held by Carlyle consolidated in one spreadsheet with up to 7 years of data
Download as csv

Portfolio Holdings for Carlyle Group
Carlyle Group holds 30 positions in its portfolio as reported in the March 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Quidel Corp (QDEL) | 33.1 | $1.1B | 13M | 89.09 |
|
|
ZoomInfo Technologies Common Stock (ZI) | 27.0 | $906M | 37M | 24.71 |
|
|
MKS Instruments (MKSI) | 22.4 | $752M | 8.5M | 88.62 |
|
|
Vitru Ord (VTRU) | 4.2 | $142M | 6.2M | 22.76 |
|
|
GDS Hldgs Sponsored Ads (GDS) | 2.3 | $76M | +7% | 4.1M | 18.66 |
|
Vaxcyte (PCVX) | 2.2 | $72M | NEW | 1.9M | 37.48 |
|
Getty Images Holdings Cl A Com (GETY) | 1.8 | $61M | 12M | 5.09 |
|
|
Verona Pharma Sponsored Ads (VRNA) | 1.5 | $49M | NEW | 2.5M | 20.08 |
|
Hillevax (HLVX) | 0.9 | $30M | NEW | 1.8M | 16.37 |
|
Vera Therapeutics Cl A (VERA) | 0.7 | $23M | NEW | 3.0M | 7.73 |
|
Phathom Pharmaceuticals (PHAT) | 0.6 | $21M | NEW | 2.9M | 7.11 |
|
Jasper Therapeutics (JSPR) | 0.5 | $16M | NEW | 8.8M | 1.80 |
|
Invitation Homes (INVH) | 0.4 | $15M | NEW | 478k | 31.23 |
|
Reneo Pharmaceuticals (RPHM) | 0.4 | $12M | NEW | 2.1M | 5.90 |
|
Setup an alertCarlyle will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
Adicet Bio (ACET) | 0.4 | $12M | NEW | 2.1M | 5.75 |
|
Life Storage Inc reit (LSI) | 0.3 | $11M | 86k | 131.09 |
|
|
Cubesmart (CUBE) | 0.3 | $10M | 221k | 46.22 |
|
|
Seacor Marine Hldgs (SMHI) | 0.3 | $10M | +9% | 1.3M | 7.61 |
|
Spruce Biosciences (SPRB) | 0.2 | $6.4M | NEW | 2.9M | 2.21 |
|
Smart Sh Global Ads (EM) | 0.2 | $5.3M | 4.8M | 1.11 |
|
|
Nucana Sponsored Adr (NCNA) | 0.1 | $3.2M | NEW | 3.3M | 0.96 |
|
Paratek Pharmaceuticals (PRTK) | 0.1 | $2.6M | NEW | 1.0M | 2.52 |
|
Soleno Therapeutics (SLNO) | 0.1 | $2.5M | NEW | 1.2M | 2.11 |
|
Effector Therapeutics (EFTR) | 0.1 | $1.7M | NEW | 4.8M | 0.35 |
|
Cymabay Therapeutics (CBAY) | 0.0 | $1.1M | NEW | 131k | 8.73 |
|
Meta Data Sponsored Ads (AIU) | 0.0 | $329k | 314k | 1.05 |
|
|
Sientra | 0.0 | $256k | NEW | 167k | 1.53 |
|
Exicure Com New (XCUR) | 0.0 | $242k | NEW | 282k | 0.86 |
|
Molecular Templates (MTEM) | 0.0 | $75k | NEW | 200k | 0.38 |
|
Aeglea Biotherapeutics (AGLE) | 0.0 | $69k | NEW | 241k | 0.29 |
|
Past Filings by Carlyle Group
SEC 13F filings are viewable for Carlyle Group going back to 2012
- Carlyle Group 2023 Q1 filed May 5, 2023
- Carlyle Group 2022 Q4 filed Feb. 10, 2023
- Carlyle Group 2022 Q3 filed Nov. 10, 2022
- Carlyle Group 2022 Q2 filed Aug. 12, 2022
- Carlyle Group 2022 Q1 filed May 13, 2022
- Carlyle Group 2021 Q4 filed Feb. 11, 2022
- Carlyle Group 2021 Q3 filed Nov. 12, 2021
- Carlyle Group 2021 Q2 filed Aug. 12, 2021
- Carlyle Group 2021 Q1 filed May 14, 2021
- Carlyle Group 2020 Q4 filed Feb. 12, 2021
- Carlyle Group 2020 Q3 filed Nov. 13, 2020
- Carlyle Group 2020 Q2 filed Aug. 13, 2020
- Carlyle Group 2020 Q1 filed May 13, 2020
- Carlyle Group 2019 Q4 filed Feb. 13, 2020
- Carlyle Group 2019 Q3 filed Nov. 13, 2019
- Carlyle Group 2019 Q2 filed Aug. 13, 2019